Invention Grant
- Patent Title: Heteroaryl substituted pyridyl compounds useful as kinase modulators
-
Application No.: US14441705Application Date: 2013-11-07
-
Publication No.: US09657009B2Publication Date: 2017-05-23
- Inventor: Rajeev S. Bhide , John V. Duncia , John Hynes , Satheesh K. Nair , William J. Pitts , Sreekantha R. Kumar , Daniel S. Gardner , Natesan Murugesan , Venkatram Reddy Paidi , Joseph B. Santella , Ramesh Sistla , Hong Wu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary D. Greenblatt
- International Application: PCT/US2013/068875 WO 20131107
- International Announcement: WO2014/074675 WO 20140515
- Main IPC: C07D213/74
- IPC: C07D213/74 ; C07D417/14 ; C07D401/14 ; C07D401/12 ; C07D407/14 ; C07D405/12 ; C07D405/14
Abstract:
Compounds having the following formula (I) or a stereoisomer or a pharmaceutically-acceptable salt thereof, wherein R2 is a monocyclic heteroaryl group, and R1, R3, R4, R5 and R6 are as defined herein, are useful as kinase modulators, including IRAK-4 inhibition.
Public/Granted literature
- US20150284382A1 HETEROARYL SUBSTITUTED PYRIDYL COMPOUNDS USEFUL AS KINASE MODULATORS Public/Granted day:2015-10-08
Information query
IPC分类:
